a research to evaluate and compare tracheal intubation with Air-Q Blocker and Ambu AuraGain in simulated difficult airway patients requiring general anaesthesia with endotracheal intubation

â??Comparative evaluation of Air-Q blocker and Ambu AuraGain supraglottic airway devices for tracheal intubation in simulated difficult airwayâ??

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/02/007826

Enrollment

100

Registered

2017-02-10

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Air-Q Blocker: will be used to maintain the patency of airway during general anaesthesia. The device will be insrted only after the induction of anaesthesia. Control Intervention1: Ambu

Eligibility

Inclusion criteria

Inclusion criteria: Age group of 18 to 60 years ASA (American Society of Anesthesiologists) physical status I and II Patients undergoing elective surgery requiring general anaesthesia with tracheal intubation

Exclusion criteria

Exclusion criteria: Patients with upper respiratory tract infection Patients with anticipated difficult airway (Airway Difficulty Score >8). Patients with increased risk of regurgitation and aspiration of gastric content Patients with a body mass index (BMI) > 35 kg.m.-2 Patients with past history of radiotherapy to the neck involving the hypopharynx Patients undergoing surgeries involving neck and oral cavity Pregnant patients

Design outcomes

Primary

Measure	Time frame
To compare the tracheal intubation with Air-Q Blocker and AuraGain in simulated difficult airway patients requiring general anaesthesia with endotracheal intubation.Timepoint: immediately after the placement of device.	—

Secondary

Measure	Time frame
To evaluate the efficacy of Air-Q Blocker and Ambu AuraGain insertion success, oropharyngeal leak pressure, fibreoptic visualization of glottis, endotracheal intubation, haemodynamic parameters and postoperative sore throat. Timepoint: 1.insertion success of device, oropharyngeal leak pressure, fibreoptic visualization of glottis, endotracheal intubation will be observed immediately after the placement of device. 2.Haemodynamic and ventilatory parameters will be recorded at the time points- Baseline, after induction, just after device insertion and at 5, 10 and 15 minutes.	—

Measure

Time frame

To evaluate the efficacy of Air-Q Blocker and Ambu AuraGain insertion success, oropharyngeal leak pressure, fibreoptic visualization of glottis, endotracheal intubation, haemodynamic parameters and postoperative sore throat. Timepoint: 1.insertion success of device, oropharyngeal leak pressure, fibreoptic visualization of glottis, endotracheal intubation will be observed immediately after the placement of device. 2.Haemodynamic and ventilatory parameters will be recorded at the time points- Baseline, after induction, just after device insertion and at 5, 10 and 15 minutes.

—

Countries

India

Contacts

Public ContactDr Rishu

Government Medical College and Hospital, Chandigarh

lkanand11@gmail.com9646121522

Outcome results